This inventor holds 2 USPTO granted patents. Top assignee: Joint Stock Company "Biocad". Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dmitrij Aleksandrovich Madera: Innovator in Chimeric Antigen Receptor Technology
Introduction
Dmitrij Aleksandrovich Madera is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors.
Latest Patents
Madera holds a patent for an "Alternative Intracellular Signalling Domain of a Chimeric Antigen Receptor." This innovation is crucial for enhancing the efficacy of immunotherapies in treating various diseases.
Career Highlights
He is currently employed at Biocad, a prominent biopharmaceutical company in Russia. His work focuses on advancing therapeutic solutions that leverage the power of the immune system.
Collaborations
Madera collaborates with esteemed colleagues, including Andrei Borisovich Ulitin and Dmitry Valentinovich Morozov, who contribute to his research and development efforts.
Conclusion
Dmitrij Aleksandrovich Madera's work in chimeric antigen receptor technology exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile